Here you can read news and press releases from Paindrainer.
MEDICON VILLAGE, LUND, SWEDEN – A health-economic study of an AI-powered digital tool, designed by Paindrainer AB (Lund) for self-management of persistent pain, has been accepted after peer review and published in Pain Medicine, the official journal of the American Academy of Pain Medicine. The study was conducted by researchers at the Swedish Institute for Health Economics (IHE), Lund University, Tufts University School of Medicine and Newton-Wellesley Hospital, and Weill Cornell Medicine.
LUND, SWEDEN – Paindrainer AB announces a successfully completed share issue of 6.0 MSEK, supported by shareholder Almi Invest and Tramontane Invest as corner investors alongside a committed group of existing and new shareholders.
MEDICON VILLAGE, LUND, SWEDEN – Paindrainer AB today announces the launch of Relivra, a unique AI-powered digital companion designed to support individuals living with persistent pain. The product offers a self-paced, interactive learning experience built on established behavioural scientific and clinical principles.
LUND, SWEDEN – Paindrainer AB, a leading innovator in digital healthcare, announces that the Japanese Patent Office has confirmed patentability of the company’s proprietary artificial-neural-network-driven platform for comprehensive, patient-centric chronic pain management.
LUND, SWEDEN – Paindrainer AB, a pioneer in the field of digital healthcare technology, is pleased to announce that the United States Patent and Trademark Office has allowed Paindrainers unique proprietary platform for 360° patient-centric chronic pain management, powered by an artificial neural network, to be patentable.
Lund, Sweden - Paindrainer AB welcomes the changes to the RTM physician fee schedule for 2026 presented by CMS earlier this month. The final ruling for 2026 presents new codes within the RTM therapy enable health care providers to have a more frequent reimbursement schedule.
Paindrainer AB is pleased to announce a commercial partnership agreement with Internal Medicine Associates of Tuscaloosa, a premier care provider located in Tuscaloosa (AL), with a mission to provide qualitative and efficient healthcare in the state. This collaboration further expands Pain drainer’s footprint in the US and the health care market.
LUND, SWEDEN – Paindrainer AB is proud to announce that the company now has successfully achieved its SOC 2 Type 2 attestation for its medical device, PD Care System, following a thorough external audit process. This milestone underscores Paindrainer’s commitment to protecting partner and patient data by meeting the highest standards of data security in digital health.
Erik Frick
CEO
[email protected]
+1 646 979 8319
Paindrainer App
JPG
Paindrainer Logotype
SVG
The Story Behind Paindrainer
Paindrainer Demo
